Live webinar Feb. 25, 2025; 1-4PM ET Feb. 26, 2025; 1-4PM ET Early Bird rate: $850 until Feb. 1, 2025. Use coupon code: EARLYFEB1 This course helps credentialing professionals and contractors identify gaps for improvement and align services with those desired by potential contracting organizations.
The Investor Relations website contains information about AbbVie’s business for stockholders, potential investors, and financial analysts.
Discover the latest news about our company, our products, our policies, and our people.
Adam Colborn, JD, of AMCP, discussed how President Trump’s rescission of several Biden-era executive orders may impact Medicaid and Medicare initiatives.
This article describes the challenges and lessons learned in conducting a major public health campaign to connect immigrant children and their parents to school-required immunizations…
Published on: January 30, 2025 Type 1 diabetes (T1D) can happen to anyone, at any age, regardless of family history. Unfortunately, up to 40% of…
Astellas Pharma still looks to grow in cancer with a pipeline that includes internally developed programs that could stand out in oncology. But the drugmaker…
2024 Revenues of $16.5 billion reflect an increase of 6%, in local currency terms, compared to 2023; AUSTEDO ® – exceeding $1.6 billion in revenues,…
Robust evidence of the clinical benefit of WINREVAIR demonstrated in the STELLAR and ZENITH studies resulted in a loss of clinical equipoise in the HYPERION…
Richard Francis, Teva Pharmaceuticals CEO, joins ‘Money Movers’ to discuss the company’s quarterly earnings results, drug price negotiations, and much more.
Drawing on organizational theory and their own semistructured interviews with C-suite leaders from 11 academic health systems, the authors share insights in this qualitative descriptive…
